<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01885065</url>
  </required_header>
  <id_info>
    <org_study_id>DIF-02</org_study_id>
    <nct_id>NCT01885065</nct_id>
  </id_info>
  <brief_title>Efficacy of Novel Edible Gel-based Artificial Saliva in Cancer Patients</brief_title>
  <official_title>Efficacy Study of Novel Edible Gel-based Artificial Saliva in Xerostomic Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dental Innovation Foundation Under Royal Patronage</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Thammasat University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Srinakharinwirot University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of Health, Thailand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dental Innovation Foundation Under Royal Patronage</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether continuous use of edible, gel-based
      artificial saliva in cancer patients with dry mouth problems will reduce signs and symptoms
      of dry mouth and improve quality of patients' saliva.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in subjective dry mouth score</measure>
    <time_frame>baseline, 2 weeks and 4 weeks after intervention</time_frame>
    <description>The outcome measure (subjective dry mouth score) will be measured before and 2 and 4 weeks after continuous usage of edible gel-based artificial saliva (30-50 ml/day for at least 5 days per week)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in objective dry mouth score</measure>
    <time_frame>Baseline, 2 week and 4 weeks after the start date</time_frame>
    <description>The outcome measure will be measured before and 2 and 4 weeks after continuous usage of edible gel-based artificial saliva (30-50 ml/day for at least 5 days per week)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in salivary pH</measure>
    <time_frame>Baseline, 2 weeks and 4 weeks after the start date</time_frame>
    <description>The outcome measure will be measured before and 2 and 4 weeks after continuous usage of edible gel-based artificial saliva (30-50 ml/day for at least 5 days per week)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in salivary buffering capacity</measure>
    <time_frame>Baseline, 2 weeks and 4 weeks after the start date</time_frame>
    <description>The outcome measure will be measured before and 2 and 4 weeks after continuous usage of edible gel-based artificial saliva (30-50 ml/day for at least 5 days per week)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Cancer of Head and Neck</condition>
  <condition>Cancer</condition>
  <condition>Radiation-induced Xerostomia</condition>
  <condition>Dry Mouth</condition>
  <arm_group>
    <arm_group_label>Gel-based artificial saliva</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Continuous oral intake of edible gel-based artificial saliva (30-50 ml/day) for four weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Gel-based artificial saliva</intervention_name>
    <description>Gel-based artificial saliva is an edible non-nutritious gel intended to relieve dry mouth.
Taking orally 1-2 teaspoon each time, 5 times / day (30-50 ml/ day) for four weeks.</description>
    <arm_group_label>Gel-based artificial saliva</arm_group_label>
    <other_name>Oral moisturizing jelly</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  cancer patients who receive/ had received radiotherapy and/or chemotherapy and have
             dry mouth problems

        Exclusion Criteria:

          -  mucositis more than grade 1

          -  cannot perform oral intake of gel-based artificial saliva eg. aspirate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aroonwan Lam-ubol, DDS, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Faculty of Dentistry, Srinakharinwirot University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mahavachiralongkorn cancer hospital</name>
      <address>
        <city>Pathumthani</city>
        <zip>12110</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <link>
    <url>http://www.dent-in-found.org/</url>
    <description>Dental Innovation Foundation under Royal Patronage, His Majesty the King's Dental Service Unit</description>
  </link>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 16, 2013</study_first_submitted>
  <study_first_submitted_qc>June 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2013</study_first_posted>
  <last_update_submitted>June 19, 2013</last_update_submitted>
  <last_update_submitted_qc>June 19, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Xerostomia</mesh_term>
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

